Liste des publications
Publications du département d'ophtalmologie
Bienvenue sur la page dédiée aux publications scientifiques du département d'ophtalmologie du centre médical des Aravis. Notre équipe médicale s'investit activement dans la recherche et l'innovation afin d'améliorer constamment la prise en charge de nos patients. Nos travaux portent sur un large éventail de thématiques, notamment :
Domaines d'expertise
- Les maladies de la cornée, telles que le kératocône, et les techniques chirurgicales associées (greffe de cornée, etc.).
- Les pathologies rétiniennes, comme la DMLA ou le décollement de la rétine, avec une expertise particulière dans les traitements par injections intravitréennes et la chirurgie vitréo-rétinienne.
- L'épidémiologie et la santé publique en ophtalmologie, en utilisant des bases de données nationales pour analyser les tendances et les facteurs de risque de différentes maladies oculaires.
- L'impact des technologies numériques sur la santé oculaire, notamment l'utilisation de la télémédecine pour le dépistage de la rétinopathie diabétique.
Nous sommes fiers de partager ici nos contributions à l'avancement des connaissances en ophtalmologie. N'hésitez pas à consulter nos publications pour en savoir plus sur nos domaines d'expertise et nos recherches en cours.
2022
Merad, Malik; Vérité, Fabien; Baudin, Florian; Ghezala, Inès Ben; Meillon, Cyril; Bron, Alain Marie; Arnould, Louis; Eid, Pétra; Creuzot-Garcher, Catherine; Gabrielle, Pierre-Henry
Cystoid macular edema after rhegmatogenous retinal detachment repair with pars Plana vitrectomy: Rate, risk factors, and outcomes Article de journal
Dans: J. Clin. Med., vol. 11, no. 16, p. 4914, 2022.
Résumé | BibTeX | Étiquettes: cystoid macular edema; pars plana vitrectomy; rhegmatogenous retinal detachment; spectral-domain optical coherence tomography; vitreoretinal surgery
@article{Merad2022-my,
title = {Cystoid macular edema after rhegmatogenous retinal detachment
repair with pars Plana vitrectomy: Rate, risk factors, and
outcomes},
author = {Malik Merad and Fabien Vérité and Florian Baudin and Inès Ben Ghezala and Cyril Meillon and Alain Marie Bron and Louis Arnould and Pétra Eid and Catherine Creuzot-Garcher and Pierre-Henry Gabrielle},
year = {2022},
date = {2022-08-01},
journal = {J. Clin. Med.},
volume = {11},
number = {16},
pages = {4914},
publisher = {MDPI AG},
abstract = {(1) Background: The aim was to describe the rate and outcomes of
cystoid macular edema (CME) after pars plana vitrectomy (PPV)
for primary rhegmatogenous retinal detachment (RRD) and to
identify risk factors and imaging characteristics. (2) Methods:
A retrospective consecutive case study was conducted over a
5-year period among adult patients who underwent PPV for primary
RRD repair. The main outcome measure was the rate of CME at 12
months following PPV. (3) Results: Overall, 493 eyes were
included. The CME rate was 28% (93 patients) at 12 months. In
multivariate analysis, eyes with worse presenting visual acuity (VA) (odds ratio [OR], 1.55; 95% CI, 1.07-2.25; p = 0.02) and
grade C proliferative vitreoretinopathy (PVR) (OR, 2.88; 95% CI, 1.04-8.16; p = 0.04) were more at risk of developing CME 1
year after PPV. Endolaser retinopexy was associated with a
greater risk of CME than cryotherapy retinopexy (OR, 3.06; 95% CI, 1.33-7.84; p = 0.01). Eyes undergoing cataract surgery
within 6 months of the initial RRD repair were more likely to develop CME at 12 months (OR, 1.96; 95% CI, 1.06-3.63; p =
0.03). (4) Conclusions: CME is a common complication after PPV
for primary RRD repair. Eyes with worse presenting VA, severe
PVR at initial presentation, endolaser retinopexy, and cataract
surgery within 6 months of initial RRD repair were risk factors
for postoperative CME at 12 months.},
keywords = {cystoid macular edema; pars plana vitrectomy; rhegmatogenous retinal detachment; spectral-domain optical coherence tomography; vitreoretinal surgery},
pubstate = {published},
tppubtype = {article}
}
cystoid macular edema (CME) after pars plana vitrectomy (PPV)
for primary rhegmatogenous retinal detachment (RRD) and to
identify risk factors and imaging characteristics. (2) Methods:
A retrospective consecutive case study was conducted over a
5-year period among adult patients who underwent PPV for primary
RRD repair. The main outcome measure was the rate of CME at 12
months following PPV. (3) Results: Overall, 493 eyes were
included. The CME rate was 28% (93 patients) at 12 months. In
multivariate analysis, eyes with worse presenting visual acuity (VA) (odds ratio [OR], 1.55; 95% CI, 1.07-2.25; p = 0.02) and
grade C proliferative vitreoretinopathy (PVR) (OR, 2.88; 95% CI, 1.04-8.16; p = 0.04) were more at risk of developing CME 1
year after PPV. Endolaser retinopexy was associated with a
greater risk of CME than cryotherapy retinopexy (OR, 3.06; 95% CI, 1.33-7.84; p = 0.01). Eyes undergoing cataract surgery
within 6 months of the initial RRD repair were more likely to develop CME at 12 months (OR, 1.96; 95% CI, 1.06-3.63; p =
0.03). (4) Conclusions: CME is a common complication after PPV
for primary RRD repair. Eyes with worse presenting VA, severe
PVR at initial presentation, endolaser retinopexy, and cataract
surgery within 6 months of initial RRD repair were risk factors
for postoperative CME at 12 months.
Explorer
Recherche
Merad, Malik; Vérité, Fabien; Baudin, Florian; Ghezala, Inès Ben; Meillon, Cyril; Bron, Alain Marie; Arnould, Louis; Eid, Pétra; Creuzot-Garcher, Catherine; Gabrielle, Pierre-Henry
Cystoid macular edema after rhegmatogenous retinal detachment repair with pars Plana vitrectomy: Rate, risk factors, and outcomes Article de journal
Dans: J. Clin. Med., vol. 11, no. 16, p. 4914, 2022.
@article{Merad2022-my,
title = {Cystoid macular edema after rhegmatogenous retinal detachment
repair with pars Plana vitrectomy: Rate, risk factors, and
outcomes},
author = {Malik Merad and Fabien Vérité and Florian Baudin and Inès Ben Ghezala and Cyril Meillon and Alain Marie Bron and Louis Arnould and Pétra Eid and Catherine Creuzot-Garcher and Pierre-Henry Gabrielle},
year = {2022},
date = {2022-08-01},
journal = {J. Clin. Med.},
volume = {11},
number = {16},
pages = {4914},
publisher = {MDPI AG},
abstract = {(1) Background: The aim was to describe the rate and outcomes of
cystoid macular edema (CME) after pars plana vitrectomy (PPV)
for primary rhegmatogenous retinal detachment (RRD) and to
identify risk factors and imaging characteristics. (2) Methods:
A retrospective consecutive case study was conducted over a
5-year period among adult patients who underwent PPV for primary
RRD repair. The main outcome measure was the rate of CME at 12
months following PPV. (3) Results: Overall, 493 eyes were
included. The CME rate was 28% (93 patients) at 12 months. In
multivariate analysis, eyes with worse presenting visual acuity (VA) (odds ratio [OR], 1.55; 95% CI, 1.07-2.25; p = 0.02) and
grade C proliferative vitreoretinopathy (PVR) (OR, 2.88; 95% CI, 1.04-8.16; p = 0.04) were more at risk of developing CME 1
year after PPV. Endolaser retinopexy was associated with a
greater risk of CME than cryotherapy retinopexy (OR, 3.06; 95% CI, 1.33-7.84; p = 0.01). Eyes undergoing cataract surgery
within 6 months of the initial RRD repair were more likely to develop CME at 12 months (OR, 1.96; 95% CI, 1.06-3.63; p =
0.03). (4) Conclusions: CME is a common complication after PPV
for primary RRD repair. Eyes with worse presenting VA, severe
PVR at initial presentation, endolaser retinopexy, and cataract
surgery within 6 months of initial RRD repair were risk factors
for postoperative CME at 12 months.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
cystoid macular edema (CME) after pars plana vitrectomy (PPV)
for primary rhegmatogenous retinal detachment (RRD) and to
identify risk factors and imaging characteristics. (2) Methods:
A retrospective consecutive case study was conducted over a
5-year period among adult patients who underwent PPV for primary
RRD repair. The main outcome measure was the rate of CME at 12
months following PPV. (3) Results: Overall, 493 eyes were
included. The CME rate was 28% (93 patients) at 12 months. In
multivariate analysis, eyes with worse presenting visual acuity (VA) (odds ratio [OR], 1.55; 95% CI, 1.07-2.25; p = 0.02) and
grade C proliferative vitreoretinopathy (PVR) (OR, 2.88; 95% CI, 1.04-8.16; p = 0.04) were more at risk of developing CME 1
year after PPV. Endolaser retinopexy was associated with a
greater risk of CME than cryotherapy retinopexy (OR, 3.06; 95% CI, 1.33-7.84; p = 0.01). Eyes undergoing cataract surgery
within 6 months of the initial RRD repair were more likely to develop CME at 12 months (OR, 1.96; 95% CI, 1.06-3.63; p =
0.03). (4) Conclusions: CME is a common complication after PPV
for primary RRD repair. Eyes with worse presenting VA, severe
PVR at initial presentation, endolaser retinopexy, and cataract
surgery within 6 months of initial RRD repair were risk factors
for postoperative CME at 12 months.